Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia

Journal of Perinatology

Volumn 29, Issue 9, 2009, Pages 612-617

  Maisels, M J ^a   DeRidder, J M ^a   Kring, E A ^a   Balasubramaniam, M ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; ARTIFICIAL MILK; BILIRUBIN BLOOD LEVEL; BREAST FEEDING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HEMATOMA; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERBILIRUBINEMIA; INFANT; JAUNDICE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN CARE; PHOTOTHERAPY; PREDICTOR VARIABLE; RISK FACTOR; SKIN BRUISING;

ADULT; BILIRUBIN; BREAST FEEDING; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; MALE; ODDS RATIO; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 69749107918     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.43     Document Type: Article

References (23)

1. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Clinical practice guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
2. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns. Pediatrics 1999; 103: 6-14.
3. Alpay F, Sarici S, Tosuncuk HD, Serdar MA, Inanc N, Gokcay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics 2000; 106: E16.
4. Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr 2001; 90: 166-170.
5. Kaplan M, Hammerman C, Feldman R, Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2000; 105: 533-537.
6. Stevenson DK, Fanaroff AA, Maisels MJ, Young BWY, Wong RJ, Vreman HJ et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001; 108: 31-39.
7. Newman T, Liljestrand P, Escobar G. Combining clinical risk factors with bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med 2005; 159: 113-119.
8. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani V. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 2008; 121: E170-e179.
9. Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 or more weeks0 of gestation. Pediatrics 2006; 117: 1169-1173.
10. Newman TB, Browner WS, Cummings SR, Hulley SB. Designing an observational study; cross-sectional and case-controlled studies In: Hulley SB, Cummings SR, Browner, Browner WS, Grady D, Hearst N et al (eds). Designing Clinical Research. 2nd edn. Williams and Wilkins: Philadelphia, PA, 2001, pp 107-123.
11. DeLong E, DeLong D, Clarke-Pearson D. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-845.
12. Davidson LT, Merritt KK, Weech AA. Hyperbilirubinemia in the newborn. Am J Dis Child 1941; 61: 958-980.
13. Knudsen A. Prediction of the development of neonatal jaundice by increased umbilical cord blood bilirubin. Acta Pediatr Scand 1989; 78: 217-221.
14. Saigal S, Lunyk O, Bennett KJ, Patterson MC. Serum bilirubin levels in breast- and formula-fed infants in the first 5 days of life. Can Med Assoc J 1982; 127: 985-989.
15. Bhutani V, Gourley GR, Adler S, Kreamer B, Dalman C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000; 106: E17.
16. Maisels MJ, Ostrea Jr E, Touch S, Clune S, Cepeda E, Kring E et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics 2004; 113: 1628-1635.
17. Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, bilicheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr 2002; 91: 203-211.
18. Rubaltelli F, Gourley GR, Loskamp N, Modi N, Roth-Kleiner M, Sender A et al. Transcutaneous bilirubin measurement: A multicenter evaluation of a new device. Pediatrics 2001; 107: 1264-1271.
19. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs 2006; 35: 444-455.
20. Maisels MJ, Kring EA. Length of stay, jaundice and hospital readmission. Pediatrics 1998; 101: 995-998.
21. Maisels MJ, Kring E. Routine transcutaneous bilirubin (TcB) measurements in the nursery predict the risk of subsequent hyperbilirubinemia. E-PAS 2006; 59: 5575.479.
22. Eggert L, Wiedmeier SE, Wilson J, Christensen R. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006; 117: e855-e862.
23. Kuzniewicz MW, Escobar GJ, Newman TB. The impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use in a managed care organization. Pediatrics 2009 (in press).